←Back to Expert Scholars
Translational Medicine / 转化医学POLE Hypermutated and Molecular, Endometrial
Nicoletta Colombo
MD
🏢European Institute of Oncology (IEO) and University of Milan-Bicocca🌐Italy
Director, Division of Gynecologic Oncology
95
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Nicoletta Colombo led the RUBY trial of dostarlimab plus chemotherapy in advanced endometrial cancer showing benefit especially in MMR-deficient disease. She directs gynecologic oncology at the European Institute of Oncology in Milan. She is a past president of ESGO.
Share:
🧪Research Fields 研究领域
RUBY trial
dostarlimab endometrial
ovarian cancer
European cooperative groups
ESGO
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Nicoletta Colombo 的研究动态
Follow Nicoletta Colombo's research updates
留下邮箱，当我们发布与 Nicoletta Colombo（European Institute of Oncology (IEO) and University of Milan-Bicocca）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment